-Bronchial wall area percent (WA% ϭ 100 ϫ wall area/total bronchial cross sectional area) is a standard computed tomographic (CT) measure of central airway morphology utilized in smokers with chronic obstructive pulmonary disease (COPD). Although it provides significant clinical correlations, the range of reported WA% is narrow. This suggests limited macroscopic change in response to smoking or that remodeling proportionally affects the airway wall and lumen dimensions such that their ratio is preserved. The objective of this study is to assess central airway wall area (WA), lumen area (Ai), and total bronchial area (Ao) from CT scans of 5,179 smokers and 92 never smoking normal subjects. In smokers, WA, Ai, and Ao were positively correlated with forced expiratory volume in 1 s (FEV1) expressed as a percent of predicted (FEV1%), and the WA% was negatively correlated with FEV1% (P Ͻ 0.0001 for all comparisons). Importantly, smokers with lower FEV1% tended to have airways of smaller cross-sectional area with lower WA. The increases in the WA% across GOLD stages of chronic obstructive pulmonary disease (COPD) can therefore not be due to increases in WA. The data suggest two possible origins for the WA% increases: 1) central airway remodeling resulting in overall reductions in airway caliber in excess of the decreased WA or 2) those with COPD had smaller native airways before they began smoking. In both cases, these observations provide an explanation for the limited range of values of WA% across stages of COPD. lumen; wall area; chronic obstructive pulmonary disease; computed tomographic scan SMOKING-RELATED AIRWAY DISEASE is believed to manifest on computed tomographic (CT) scan as airway wall thickening with encroachment on the airway lumen (10). For the purposes of functional, genetic, and epidemiological investigations utilizing CT scans of the chest, this remodeling process is most commonly presented as wall area percent (WA% ϭ wall area/total bronchial cross-sectional area ϫ 100). Additional measures of bronchial morphology such as wall area (WA), lumen area (Ai), and total bronchial area (Ao ϭ WA ϩ Ai) have been explored but are poorer predictors of lung function (5, 10). In fact, although not reaching statistical significance, Nakano et al. (10) reported that the Ao of the apical segment of the right upper lobe (RB1) may be directly correlated to a subject's forced expiratory volume in 1 s (FEV 1 ) expressed as a percent of predicted (FEV 1 %); those with greater Ao in RB1 bronchi tended to have less obstruction determined spirometrically.
-Bronchial wall area percent (WA% ϭ 100 ϫ wall area/total bronchial cross sectional area) is a standard computed tomographic (CT) measure of central airway morphology utilized in smokers with chronic obstructive pulmonary disease (COPD). Although it provides significant clinical correlations, the range of reported WA% is narrow. This suggests limited macroscopic change in response to smoking or that remodeling proportionally affects the airway wall and lumen dimensions such that their ratio is preserved. The objective of this study is to assess central airway wall area (WA), lumen area (Ai), and total bronchial area (Ao) from CT scans of 5,179 smokers and 92 never smoking normal subjects. In smokers, WA, Ai, and Ao were positively correlated with forced expiratory volume in 1 s (FEV1) expressed as a percent of predicted (FEV1%), and the WA% was negatively correlated with FEV1% (P Ͻ 0.0001 for all comparisons). Importantly, smokers with lower FEV1% tended to have airways of smaller cross-sectional area with lower WA. The increases in the WA% across GOLD stages of chronic obstructive pulmonary disease (COPD) can therefore not be due to increases in WA. The data suggest two possible origins for the WA% increases: 1) central airway remodeling resulting in overall reductions in airway caliber in excess of the decreased WA or 2) those with COPD had smaller native airways before they began smoking. In both cases, these observations provide an explanation for the limited range of values of WA% across stages of COPD. lumen; wall area; chronic obstructive pulmonary disease; computed tomographic scan SMOKING-RELATED AIRWAY DISEASE is believed to manifest on computed tomographic (CT) scan as airway wall thickening with encroachment on the airway lumen (10) . For the purposes of functional, genetic, and epidemiological investigations utilizing CT scans of the chest, this remodeling process is most commonly presented as wall area percent (WA% ϭ wall area/total bronchial cross-sectional area ϫ 100). Additional measures of bronchial morphology such as wall area (WA), lumen area (Ai), and total bronchial area (Ao ϭ WA ϩ Ai) have been explored but are poorer predictors of lung function (5, 10) . In fact, although not reaching statistical significance, Nakano et al. (10) reported that the Ao of the apical segment of the right upper lobe (RB1) may be directly correlated to a subject's forced expiratory volume in 1 s (FEV 1 ) expressed as a percent of predicted (FEV 1 %); those with greater Ao in RB1 bronchi tended to have less obstruction determined spirometrically.
Although there are highly statistically significant correlations between the airway WA% and the FEV 1 , forced vital capacity (FVC), and FEV 1 /FVC (7, 10) , there is a very narrow range of WA% found in a cohort of subjects with chronic obstructive pulmonary disease (COPD) spanning all degrees of disease severity. Coxson et al. noted that in the fifth-generation airway, WA% ranged between ϳ68 and 75% in a cohort whose FEV 1 was 40 -120% of predicted (2) . The direct relationship between both Ao and Ai with lung function suggests that those with more severe COPD have smaller airways with narrower lumens. If smoking-related central airway remodeling manifests as geometrically similar reductions in all components of the airway (specifically WA, Ao, and Ai), a summary statistic such as the WA%, being a dimensionless ratio, would be relatively insensitive to this process despite the magnitude of these changes.
We therefore sought to further examine the nature of central airway remodeling in smokers and more specifically how airway WA is related to the Ao across different spirometric stages of COPD severity. Based on prior work by Tiddens et al. (15) , we anticipated that those subjects with the greatest wall areas would have the most severe expiratory airflow obstruction. To carry out this investigation, we examined CT, epidemiological, and spirometric data from over 5,000 subjects enrolled in the COPDGene Study, including 92 life-long nonsmokers with normal lung function.
of identifying genetic predictors of the disease. Included in this investigation were additional airway data from 92 never-smokers with normal lung function and no history of lung disease (19) . Subjects with active lung diseases other than asthma, emphysema, or COPD were excluded. The COPDGene Study was approved by the institutional review board (IRB) of all participating centers.
Spirometric measures of lung function [FEV 1, FVC, and the ratio of FEV1 to FVC (FEV1/FVC)] were performed using the Easy-One spirometer (ndd Medical Technologies, Andover, MA) before and after administration of a short-acting inhaled bronchodilating medication (albuterol) per American Thoracic Society recommendations (1) . These measures were expressed as a percent of predicted values for age, height, race, and gender (3) . From these data, subjects could be classified into the GOLD stages of disease severity (12) . Smokers with no evidence of spirometric obstruction (FEV 1/FVC Ͼ 0.7) were categorized as being "at risk" for the development of COPD. In our investigation, smokers with a proportionally reduced FEV1 and FVC with preserved ratio (GOLD U) were excluded from analysis (17) .
CT scans. Volumetric CT scans of the chest were performed at both maximal inflation and relaxed exhalation (13) . Morphometric assessment of the airways was performed on the maximally inflated scans using VIDA software (Vida Diagnostics, Iowa City, IA), as described previously (8) . Briefly, the lumen-wall and wall-parenchymal boundaries were localized simultaneously in 3D using both density information (i.e., transition in density between structures) as well as a priori assumptions of biologically plausible airway structures. These borders were then represented in a graph structure, and an optimization process was used to detect the final edges (8, 16) . The image resolution was dependent on both the slice thickness (z), which ranged from 0.5 to 0.75 mm, and the in-plane pixel size, which was determined by the field of view (FOV). The image voxel size in COPDGene ranged from 0.2 to 0.6 mm 3 , with a mean value of 0.3 mm 3 . For the purposes of this investigation, data were collected from the segmental and subsegmental generations of the apical segment of the right upper lobe (RB1) and the posterior-basal segmental and subsegmental bronchi of the right lower lobe (RB10). Measures of airway WA, Ai, Ao, and WA% were calculated. Low attenuation areas (LAA) thought to reflect emphysematous destruction of the lung parenchyma were defined using a Hounsfield Unit threshold of Ϫ950 (%LAA-950).
Analysis. Data are presented as means Ϯ SD and compared using t-tests. Univariate linear regression was used to examine the relationship between CT measures of airway morphology (WA, Ai, Ao, WA%) and lung function assessed by FEV 1 expressed as percent predicted (FEV1%). The dependence of airway morphology on FEV1% was expressed as Pearson correlation coefficients. Airway morphology was further adjusted for sex, height, age at the time of CT scanning, and %LAA-950 in subsequent multivariate linear regression. Differences in airway morphology (WA, Ao, Ai, WA%) were compared across GOLD stages using ANOVA. Statistical analysis was performed using SAS 9.2 (Carey, NC). P values of Ͻ0.05 were considered statistically significant.
RESULTS
We first examined central airway morphology among smokers. Baseline characteristics of this group are outlined in Table 1 . A total of 5,179 COPDGene Study subjects with complete segmental airway CT data were included in this investigation. A subset of 2,717 of these subjects also had additional complete subsegmental RB1 and RB10 airway data available for analysis. For all comparisons, there was a direct relationship between WA and FEV 1 % (P Ͻ 0.0001), a direct relationship between Ai and FEV 1 % (P Ͻ 0.0001), a direct relationship between Ao and FEV 1 % (P Ͻ 0.0001), and an inverse relationship between WA% and FEV 1 % (P Ͻ 0.0001) for both the segmental (n ϭ 5,179) and subsegmental (n ϭ 2,717) airway generations of RB1 and RB10 (Table 2) . Statistically significant associations between the WA, Ai, Ao, and WA% and the FEV 1 % held after adjustment for sex, height, and age (data not shown). 
Morphometric assessments (WA, Ai, Ao, and WA%) of RB1 and RB10 segmental airways as a function of GOLD stage are presented in Tables 3 (men) and 4 (women) and Fig. 1 . In general, the mean segmental wall area, lumen area, and total bronchial area of both RB1 and RB10 decreased with higher GOLD stages for both men and women. Later stages of disease were characterized by reductions in the size of Ao, including both its wall and lumen. However, it also appeared that airway lumen decreased at a slightly faster rate than the airway wall, such that the net effect is only a subtle increase in WA%. This can also be seen in Tables 3-6 for the segmental and subsegmental airways. Figure 2 provides visual representations of bronchi in RB10 (segmental generation) in axial CT scan images from a smoker with normal lung function and a smoker with GOLD 4 disease. These images are examples showing that, in GOLD 4 disease, the total bronchial area is reduced, with a resulting smaller lumen and wall area.
COPDGene also included a cohort of 92 never-smokers (29 men and 63 women) with no history of lung disease and whose FEV 1 ranged from 80 to 120% of predicted (mean 103.5%) ( Table 1) . Using CT data from these subjects, we sought to determine whether quantitative assessments of airway morphology were related to lung function in a fashion similar to what was observed in the smokers. To do this, we began by examining the associations between WA, Ai, Ao, and WA% and the FEV 1 % ( Table 2 ). For the segmental airways, RB1 morphology was not associated with lung function. By contrast, RB10 morphologies (WA, Ai, Ao, and WA%) were all significantly associated with the FEV 1 %. Similarly, in the subsegmental airways, objective measures of both RB1 (n ϭ 91) and RB10 (n ϭ 92) were all significantly associated with FEV 1 %. The magnitude and direction of these associations was similar to that observed in the smokers (Table 2) .
DISCUSSION
This analysis of over 5,000 participants in the COPDGene Study investigated CT-based measures of airway morphology in normal never-smokers and smokers exhibiting progressive stages of COPD. As demonstrated previously (2, 10), we observed that those smokers with the greatest segmental WA% tended to have the greatest degree of expiratory airflow obstruction. Furthermore, we found that both never-smoking normals and smokers with lower FEV 1 % had smaller WA, Ai, and Ao of both RB1 and RB10 bronchi; those with the smallest total bronchial area also had the largest WA%. The strength and direction of the correlation between measures of airway Data are shown for never-smoking normals, smokers with normal lung function (at risk), and those with GOLD stages 1-4 disease. P values are provided for the comparisons of never-smokers and the at risk cohort. Areas are presented in mm 2 . *Significant difference for comparisons between the never-smokers and smokers with normal lung function (at risk) (P Ͻ 0.05). †Significant difference for differences in airway morphology across GOLD stages 1-4 (P Ͻ 0.05). morphology and the FEV 1 % were similar in the never-smokers and smokers with COPD. Finally, we found that, in smokers with COPD, increases in WA% in successive GOLD stages was due to greater reductions in Ao compared with the more modest decrease in wall thickness. Note that our data strongly imply that increased WA% with disease is not due to isolated wall thickening with encroachment on the lumen. Prior investigation suggests that central airway morphology is a measure of the remodeling process due to chronic tobacco smoke exposure. It is therefore interesting to find similar associations in a cohort of life-long nonsmokers with no history of lung disease. In these normals, those with the lower FEV 1 % had lower WA, Ai, and Ao, with an increased airway WA%. This finding is consistent with data reported from the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study, in which airway lumen diameter was related to FEV 1 in neversmokers and smokers (5) . In addition, it is surprising that the strength of these associations varied by lung lobe and airway Data are shown for never-smoking normals, smokers with normal lung function (at risk), and those with GOLD stages 1-4 disease. P values are provided for the comparisons of never-smokers and the at risk cohort. Areas are presented in mm 2 . *Significant difference for comparisons between the never-smokers and smokers with normal lung function (at risk) (P Ͻ 0.05). †Significant difference for differences in airway morphology across GOLD stages 1-4 (P Ͻ 0.05). generation in a manner reported for smoking-related disease. In particular, consistent with data from Hasegawa et al. in 50 male smokers (7), we found that the strongest correlates with lung function tended to occur in the right lower lobe and in the more distal airway generations. These findings may be due to occult noxious exposure in these subjects not detected at study screening or may suggest that the central airway morphology observed in smokers is dominated by native airway structure. Subjects with more severe COPD may have started with smaller airways that were more vulnerable to obstruction following chronic exposure to tobacco smoke (6) .
In smokers, we found that those with the most severe expiratory airflow obstruction tended to have the smallest WA, Ai, and Ao and the greatest WA% for each of the airway segments examined. In addition to a possible influence of native airway structure, airway remodeling induced by tobacco smoke, especially in early stages of the disease, may be characterized by progressive reductions in total bronchial area (which would serve to increase the WA%, especially if the wall area itself does not change appreciably, and somewhat paradoxically in later stages of the disease where decreases in wall area are more than offset by decreased total bronchial area). In this case, it would be the ultimate balance of these processes that favors increases in WA% in subjects with progressive spirometric obstruction, i.e., although the airway wall area may be declining, there is still a proportionately greater reduction in the total bronchial area.
Our results are compatible with prior CT and histopathological investigation. Similar to our observed trend in WA between never-smokers and the earlier stages of disease (normal smokers and GOLD 1), Tiddens et al. (14) found that, in smokers undergoing lung resection for possible malignancy, the central airways of smokers with earlier stages of disease (mean FEV 1 94% predicted, mean FEV 1 /FVC 69% predicted) tended to have increased wall area. Nakano and colleagues (11) reported that thickening of the central airway walls on CT scan predicted greater spirometric obstruction and greater burdens of small airway disease on histopathological examination. More recently, using optical coherence tomography (OCT) with a resolving capability of micrometers (rather than millimeters, as found in CT scan) Coxson et al. (2) found that increases in the WA% of the fifth generation airways were inversely related to lung function. Our results also demonstrate that those subjects with the greatest WA% also tended to have the greatest spirometric impairment. We suggest that these observations may be due to contributions of native airway structure and a more complex remodeling process than previously appreciated.
With respect to the remodeling process, it is unknown what drives the quantitative relationship between changes in, e.g., airway wall and total or lumenal bronchial area. Since these variables are correlated both in normals and in smokers over GOLD stages, and are intimately associated with the connection between structure and function, it invites an allometric examination based on power law scaling arguments. Are there similarities to what has been observed in prior analogous investigations of mammalian vessels, both airway and vascular? The relative insensitivity of WA% in the face of similar degrees of decrease in WA and Ao with disease progression suggests a common origin to both the radial changes in the airway (WA) as well as the circumferential changes (Ao and Ai). Scaling relationships may shed light on these questions, but which for now must remain open.
Despite this being one of the largest CT-based investigations of central airway morphology in smokers, this analysis is limited by the cross-sectional nature of the data. Here, we have inferred that airway morphology observed across GOLD stages represents disease progression. Substantiation of these findings will require longitudinal studies. A second limitation that must be mentioned is the nature of the CT images. Although these data were reconstructed with near isotropic voxels, our measures of airway morphology (such as WA and Ai) approach the limits of spatial resolution and are therefore likely to be overestimates of their true values. This effect would tend to be greatest in the smallest airways. Finally, it must be noted that our results represent a cohort with complete airway measures. Recent work by our group and by McDonough et al. suggests that subjects with more severe COPD tend to have fewer distal and proximal airways (4, 9) . The characterization of airway dropout in this cohort is beyond the scope of this investigation. Further work is needed to examine the clinical associations of this process and any relation to central airway morphology in smokers.
In summary, using a large sample of data from the COPDGene Study, we examined CT measures of central airway remodeling. In the smokers, we observed that those with greater spirometric impairment had reduced WA, Ai, and Ao, with increases in WA%. Furthermore, we report similar trends in airway morphology in normals; the WA, Ai, and Ao were reduced and the WA% was increased in proportion to decrements in FEV 1 %. Because this is a cross-sectional study, we cannot ascertain whether airway morphology in smokers is a product of similar reductions in WA and Ai due to chronic tobacco smoke exposure or whether the smokers with more severe COPD simply had smaller native airways. The presence of either or both could explain the relative insensitivity of WA% for the clinical manifestations of COPD and would certainly support the search for additional CT-based metrics of airway remodeling.
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